Abstract A precise knowledge of depth of invasion of tumor is essential for the planning of treatment of rectal cancer. TRUS is a new diagnostic modality that has become useful in determining depth of invasion preoperatively and the presence or absence of metastatic lymph nodes. Our aim was to determine Role of Transrectal Ultrasound in Preoperative Local Staging of Carcinoma Rectum and it's Histopathological Correlation. TRUS was used in preoperative local staging of 30 patients with carcinoma rectum. 25patients underwent APR (abdomino-perineal resection) & 5 underwent AR. (anterior resection). Preoperative TRUS staging was compared with pathological staging obtained from biopsy of resected specimen. In staging depth of invasion of rectal wall (Tstage) overall accuracy was 83.3 %, over staged 10 %, under staged in 6.67 % sensitivity was 92.5 %, and specificity was 62.5 %. In staging lymph nodes (N stage) overall accuracy was 76.67 %, sensitivity was 79.31 %, specificity was 87.5 %. TRUS is a safe and accurate preoperative local staging method for assessment of both depth of invasion of rectal wall and presence or absence of metastatic lymph nodes.
Introduction
Since the era of Miles and Dukes , surgeons and pathologists have sought to improve their ability to predict more accurately the outcome of patients with carcinoma rectum. While the western countries have envisaged better techniques to deal with the problem, the picture in our country still remains bleak. Most of our patients present with advanced growth, and a loop colostomy or at the most a palliative resection is all that is achieved. Preoperative evaluation of rectal cancer is important in planning therapy & accessing prognosis. Precise knowledge of depth of invasion of rectal cancer is essential for the planning of optimal therapy for patients with rectal cancer. Clinical examination is not entirely reliable, even though many information can be obtained. CT and MRI are also reliable for assessing advanced rectal cancer in evaluating the invasion of adjacent organs or complications. Methods of preoperative staging include digital rectal examination, proctoscopy, CT scan (abdomen and pelvis), transrectal ultrasound, endorectal coil MRI, and PET scan.
The transrectal ultrasonography (TRUS) is a new diagnostic modality that has become useful in aiding the surgeon in selecting the appropriate therapy for rectal cancer because of its high accuracy in determining the depth of invasion of rectal cancer (T stage) and presence or absence of metastatic lymph nodes (N stage) preoperatively. It is easily performed in an office setting at the time of initial patient evaluation, causes minimal discomfort, and requires only an enema for preparation.
Material and Methods
A total of 30 patient with biopsy-proven carcinoma rectum fulfilling the inclusion criteria admitted to the Department of General Surgery, SMS Medical and Hospital, Jaipur, from August 2008 to June 2010, were included in our study.
All patients underwent TRUS preoperatively, and T and N stages of TRUS were obtained. Postoperatively, the local staging obtained before surgery with TRUS was compared with the histopathological staging the resected specimen. Transrectal ultrasound was done using Toshiba Zario 7.5-10 Mhz transrectal probe. After cleansing enema and digital rectal examination, while the patient in lithotomy position, TRUS probe advanced beyond the growth with the help of proctoscope, bulb inflated with 30-60 ml of water, providing optimal acoustic pathway. Images were obtained as the transducer rotates 360°.
The rectal wall is divided into five layers based on a system proposed by Hildebrandt and Feifel [1]:
1. The inner white layer represents the interface between the balloon and the mucosa. 2. The inner dark layer represents the mucosa and muscularis mucosa. 3. The middle white layer represents the submucosa. 4. The outer dark layer represents the muscularis propria.
5.
The outermost white layer represents the interface with the perirectal fat.
The TNM (tumor, node, and metastasis) classification is used with a u-modifier to describe the depth of invasion and the presence or absence of metastatic lymph nodes as described by Beynon and coworkers [2] (Table 1 and Figs. 1 and 2) .
The following are drawbacks of transrectal ultrasound:
1. Inability to accurately stage obstructing lesions due to incomplete luminal passage of the probe 2. Inability to assess for distance metastases 3. Inherent difficulties in interpreting subtle differences between different stages of rectal wall penetration and lymph node metastases 3 Invasion through muscularis propria into perirectal fat. Outer (hyperechoic) white line (junction of muscularis propria with perirectal fat) is disrupted. uT 4 Extension into adjacent organ or structure (e.g., vagina, prostate, bladder, cervix, and seminal vesicles). Plane between any of these structures and the rectum is obliterated. N stage uN 0 Lymph node metastasis absent. uN 1 Lymph node metastasis present. 
Observations and Results
Out of 30 cases, 22 were males and 8 cases were females, with the male-to-female ratio of 2.75:1. Most common age of presentation is 50-59 years (30%). Our most cases, 24 cases out of 30 (80 %), occur in the age group of 40-69 years. The youngest patient was 20-year-old man and the oldest was 75-year-old woman. In our series, most cases were adenocarcinoma (26/30, 86.66 %) and 2 cases of mucinous adenocarcinoma (6.67 %), signet ring cell carcinoma and malignant melanoma contribute 1 cases each (3.33 %) ( Tables 2, 3 In our series, 25 patients (25/30, 83.33 %) undergone APR and 5 patients (5/30, 16.67 %) undergone anterior resection. Our no patients received new adjuvant chemoradiotherapy. We had not included such patients in our study because it can alter the accuracy of TRUS staging.
So, accuracy of TRUS for T stage in our study was 83.33 %: 10 % overstaged and 6.67 % understaged, sensitivity 92.5 %, specificity 62.5 %, positive predictive value 89.28 %, and negative predictive value 71.42 %.
In determination of presence or absence of lymph nodes (N stage), sensitivity was 79.31 %, specificity 87.5 %, positive predictive value 85.83 %, and negative predictive value 53.84 %. Six patients (6/30, 20 %) were understage because these patients had lymph nodes less than 1 cm in size on histopathological examination and these were not identified by TRUS preoperatively.
Discussion
The preoperative staging of rectal cancer impacts on treatment plans and ultimate survival. Methods of preoperative staging include digital rectal examination, proctoscopy and CT scanning, TRUS, and MRI (endorectal coil). The CT scanning has been heralded as the most accurate preoperative staging tool for rectal cancer, but its accuracy rates are not high. In addition, CT scanning is not accurate in assessing the depth of wall penetration in the rectum and appears to lack an ability to detect pelvic lymph nodes. TRUS is a new diagnostic modality that has become useful in aiding the surgeon in selecting the appropriate therapy for rectal cancer because of its high accuracy in determining the depth of invasion of the rectal cancer and the presence or absence of metastatic lymph nodes preoperatively [1, 3] . When the accuracy of ultrasonographically is determined, the depth of invasion is compared with the histologic results; accuracy rates in the 90 % range have been documented by many authors [4, 5] . Some studies have shown the superiority of transrectal ultrasonography compared to CT scanning, but others have shown little difference [3, 7] . Even though overall accuracy rates are strongly dependent on the investigator's experience. In our study, the overall accuracy determining the depth of invasion was 83.33 %-10 % was overstaged and 6.67 % was understaged. According to Kim and colleagues, in staging the depth of invasion, the overall accuracy was 88.8 %, overstaged in 5.8 %, and understaged in 5.8 % [6] . Thus, our results were comparable to other investigators for determination of the depth of invasion of the rectal wall (T stage).
There are some controversies in the interpretation of the images obtained from TRUS. It is difficult to differentiate u T 2 or u T 3 lesions clearly. It is also difficult to diagnose an u T 4 lesion because of the short focal length of the transducer. With invasive lesion confined to the submucosa, the second hyperechoic layer becomes less distinct. If the outer hyperechoic layer is enlarged, the muscle is clearly involved with the tumor and is staged an u T 2 lesion. Once the outer hyperechoic layer is shown to be incomplete, perirectal fat invasion is present and the tumor is staged u T 3 . In our under/overstaged cases, there were some blurring of hyperechoic lines. Thus, the definite depth of tumor invasion was not able to define. Understaging is more serious than overstaging since it may cause inadequate treatment. The therapeutic approach for cancer of the lower rectum-local excision versus low anterior resection-may be evaluated with the help of exact preoperative staging. It is well known that, with CT scanning, it is impossible to distinguish between T 1 and T 2 tumors. However, infiltration into the perirectal fat or into neighboring organs is more easily demonstrated. The accuracy of transrectal ultrasound in assessment of the depth of invasion of the tumor is now verified by results from numerous studies. The accuracy rate ranges from 84 to 93 %, but the CT scanning has a lower accuracy than the transrectal ultrasound in many studies as ranging from 69 to 83 % [4, 6, 7] .
Endorectal magnetic resonance imaging had been tried and its accuracy in determination of the depth of invasion was about 81 %, which was similar to that was claimed for endorectal sonography. It was also excellent for depicting perirectal lymph nodes as small as 2-3 mm in diameter.
There are many controversies about the assessment of nodal disease. Tio and Tytgat first described the hypoechoic pattern of the metastatic lymph node. Later on, Beynon et al. [2] and Hildebrandt and Feifel [1] applied Tio and Tytgat's observation to the rectum. At present, an accuracy of 72-83 % with ultrasonic diagnosis of nodal involvement is reported. It is difficult to predict the nodal involvement accurately by CT scanning because nodes smaller than 1 cm are seen only with difficulty and some visible lymph nodes may finally show reactive inflammatory changes. Glaser et al. validated that hyperechoic lymph nodes correspond to inflammatory nodes and hypoechoic lymph nodes are metastatic lymph nodes. Inflammatory nodes are more hyperechoic with more contrast. This observation is independent of the size of the nodes and surrounding fat tissue.
The accuracy of the ultrasound in the diagnosis of lymph node metastasis varies from 74 to 86 %. Beynon et al. have reported an accuracy of 83 % with a sensitivity of 88 % and specificity of 79 % [2] . This technique is considerably more accurate than CT scanning, digital examination, or magnetic resonance imaging. In our study accuracy for lymph node was 76.67 %, with sensitivity 79.31 % and specificity 87.5 %.
In our study 6/30 (20 %) were understaged (false negative) because these patients had perirectal lymph nodes less than 1 cm in size on postoperative histopathological examination and these were not identified preoperatively by TRUS.
Herzog et al. [5] reported the overall accuracy of ERUS in detecting metastatic lymph nodes to be 80 %. The accuracy based on size was higher if the nodes were larger than 5 mm (0-5 mm, 79 %; 6-10 mm, 92 %; >10 mm, 100 %).
According Kim et al. [6] , in staging of lymph nodes, the overall accuracy of TRUS was 85.3 %, sensitivity was 71.7 %, and specificity was 88.8 %. Thus, our results were comparable to other investigators in determination of N stage.
Another important application of TRUS is the early detection of local recurrence of rectal cancer by the regular interval imaging of the pelvis after anterior resection or local excision [4] .
Conclusion
TRUS is a highly accurate preoperative staging tool for rectal cancer. In other words, it shows high accuracy in determining the depth of wall penetration and high percent accuracy in assessing regional lymph nodes. It is safe and well tolerated than other imaging modalities by the patients.
